Pharmaceutical Investing Imcyse Enters into Research Collaboration and License Agreement for its Imotope Technology with Pfizer in Rheumatoid Arthritis
Algernon CEO and CSO to Discuss New DMT Stroke Clinical Research Program Featured on BioPub Webcast Hosted by Dr. KSS MD, PhD
Psychedelics Investing New Rapid mood Screener Screens for Manic Symptoms and Bipolar I Disorder Features to Address Unmet Clinical Need
Psychedelics Investing COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy
Bristol Myers Squibb and The Rockefeller University Announce License Agreement for SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19
BioHarvest Sciences Inc. Announces Closing of Oversubscribed Private Placement. Company Issues 15,449,829 Units at $0.40 per Unit for Gross Proceeds of $6,179,931.60
Life Science Investing Sixth Wave Updates on AMIPs Technology for Rapid Detection of Viruses & Mutations
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain MetastasisÂ
